| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/24/2011 | WO2010077339A3 β-ARRESTIN EFFECTORS AND COMPOSITIONS AND METHODS OF USE THEREOF |
| 02/24/2011 | WO2010043772A3 Method of protecting cells |
| 02/24/2011 | WO2010031521A3 Pancreatic polypeptide and variants thereof for use in the treatment of intestinal disorders |
| 02/24/2011 | WO2010009892A8 Compositions for the treatment of pain and/or inflamation |
| 02/24/2011 | WO2009135603A8 Method of generating hypoallergenic glycoproteins in mutated or transgenic plants or plant cells, and mutated or transgenic plants and plant cells for generating hypoallergenic glycoproteins |
| 02/24/2011 | US20110047633 Control of Exocrine Pancreatic Function Using Bone Morphogenetic Proteins |
| 02/24/2011 | US20110047631 Heat shock protein deficiencies as model systems for brain pathology and cancer |
| 02/24/2011 | US20110046606 Catheter injectable depot compositions and uses thereof |
| 02/24/2011 | US20110046538 Combination of a light ray with a cytochrome c oxidase substrate particularly for improving the appearance of the skin and/or hair |
| 02/24/2011 | US20110046360 ENA NUCLEIC ACID DRUGS MODIFYING SPLICING IN mRNA PRECURSOR |
| 02/24/2011 | US20110046356 Post-translational modifications and clostridial neurotoxins |
| 02/24/2011 | US20110046075 Secreted Staphylococcus Aureus Proteins And Peptides For Use In Inhibiting Activation Of The Complement System |
| 02/24/2011 | US20110046074 Highly permeable polymeric membranes |
| 02/24/2011 | US20110046073 Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling |
| 02/24/2011 | US20110046072 Solid pharmaceutical formulation with delayed release |
| 02/24/2011 | US20110046071 GLP-1 Receptor Agonists And Related Active Pharmaceutical Ingredients For Treatment Of Cancer |
| 02/24/2011 | US20110046070 Gene expression inhibitor selective for matrix metalloproteinase-9 gene |
| 02/24/2011 | US20110046069 Uses of Modified ELR-CXC Chemokine G31P |
| 02/24/2011 | US20110046068 Compound, Use and Method |
| 02/24/2011 | US20110046067 COMPOSITIONS COMPRISING HUMAN EGFR-siRNA AND METHODS OF USE |
| 02/24/2011 | US20110046066 Inhibitors of iap |
| 02/24/2011 | US20110046065 Low frequency glatiramer acetate therapy |
| 02/24/2011 | US20110046064 Methods and compositions using selective delta opioid receptor-1 agonists, delta opioid receptor-2 antagonists, and/or mu opioid receptor antagonists for treatment of substance-related disorders |
| 02/24/2011 | US20110046063 Ready-to-use bivalirudin compositions |
| 02/24/2011 | US20110046062 Factor h for the treatment of chronic nephropathies and production thereof |
| 02/24/2011 | US20110046061 Coagulation factor VII compositions and methods of making and using same |
| 02/24/2011 | US20110046060 Coagulation factor IX compositions and methods of making and using same |
| 02/24/2011 | US20110046059 Pharmaceutically acceptable formulations/compositions for peptidyl drugs |
| 02/24/2011 | US20110046058 Compositions for enteral absorption and sustained action of leptin-related peptides useful in the treatment of obesity and leptin-modulated disease |
| 02/24/2011 | US20110046057 Uses of cerberus and derivatives thereof |
| 02/24/2011 | US20110046056 Apoa-1 peptide mimetics |
| 02/24/2011 | US20110046055 Therapeutic agent for diabetes |
| 02/24/2011 | US20110046054 Anti diabetic protein |
| 02/24/2011 | US20110046053 Methods and compositions for oral administration of exenatide |
| 02/24/2011 | US20110046052 Excipients for Protein Stabilization |
| 02/24/2011 | US20110046051 Method and Device for Utilizing Analyte Levels to Assist in the Treatment of Diabetes |
| 02/24/2011 | US20110046050 Phenylalkylcarboxylic acid delivery agents |
| 02/24/2011 | US20110046049 Soluble, Stable Insulin-Containing Formulations with a Protamine Salt |
| 02/24/2011 | US20110046048 High protein liquid enteral nutritional composition |
| 02/24/2011 | US20110046047 Bone Morphogenetic Proteins for Appetite Control |
| 02/24/2011 | US20110046046 Prophylactic or therapeutic composition for diabetes or obesity |
| 02/24/2011 | US20110046045 Method of treating obesity and metabolic disorders related to excess adipose tissue by administration of sFRP-5 peptide |
| 02/24/2011 | US20110046044 Use of a cysteine protease of Plasmodium vivax |
| 02/24/2011 | US20110046043 Control of viral-host membrane fusion with hydrogen bond surrogate-based artificial helices |
| 02/24/2011 | US20110046042 Long Interspersed Nuclear Element Polypeptide Compositions and Methods of Use Thereof |
| 02/24/2011 | US20110046041 Methods of inhibiting and treating biofilms using glycopeptide antibiotics |
| 02/24/2011 | US20110046039 Post-exposure prophylaxis and treatment of infections |
| 02/24/2011 | US20110046038 Polypeptide-Polymer Conjugates and Methods of Use Thereof |
| 02/24/2011 | US20110045589 Methods Of Controlling Proliferation And Differentiation Of Stem And Progenitor Cells |
| 02/24/2011 | US20110045098 Excitatory glycine receptors and methods |
| 02/24/2011 | US20110045093 Pharmaceutical composition and process comprising vegetable proteolytic enzymes in supramolecular nanoparticles, for the treatment of peyronie's disease, connective tissue diseases and use |
| 02/24/2011 | US20110045073 Methods and compositions of sphingolipid for preventing and treating microbial infections |
| 02/24/2011 | US20110045061 Gene therapy for diabetic ischemic disease |
| 02/24/2011 | US20110045058 Transfection reagent |
| 02/24/2011 | US20110045051 Extracellular matrix comprising platelet factors |
| 02/24/2011 | US20110045050 Nanoemulsion formulations for direct delivery |
| 02/24/2011 | US20110045049 Immunomodulating compositions and methods of use |
| 02/24/2011 | US20110045048 Bone graft and scaffolding materials immobilized with type i collagen binding peptides |
| 02/24/2011 | US20110045047 Hemostatic implant |
| 02/24/2011 | US20110045046 Glycopeptides and methods of making and using them |
| 02/24/2011 | US20110045041 Compositions and methods for the delivery of agents |
| 02/24/2011 | US20110045034 Gelatin Sponge Comprising an Active Ingredient, Its Preparation and Use |
| 02/24/2011 | US20110045029 Oral formulation for delivery of poorly absorbed drugs |
| 02/24/2011 | US20110045017 Hiv vaccine for mucosal delivery |
| 02/24/2011 | US20110045010 Anti-lps factor from parietaria judaica and methods of use thereof |
| 02/24/2011 | US20110045008 Therapeutic agents for inducing platelet fragmentation and treating thromboembolic disorders |
| 02/24/2011 | US20110045004 Method for in-vitro detecting pathogenic t helper cells and pharmaceutical compositions for treating autoimmune diseases |
| 02/24/2011 | US20110045002 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| 02/24/2011 | US20110044999 Il-32 modulators |
| 02/24/2011 | US20110044997 Methods |
| 02/24/2011 | US20110044983 Complement inhibitors as therapeutic agents for treatment of cancer |
| 02/24/2011 | US20110044974 Peptide analogues comprising at least one type of aminoacylaza-$g(b)<sp>3</sp>and the use thereof, in particular for therapy |
| 02/24/2011 | US20110044971 Method and composition for treating a seratonin receptor-mediated condition |
| 02/24/2011 | US20110044970 Pharmaceutical compositions and methods for the treatment of dry eye |
| 02/24/2011 | US20110044969 Antimicrobial Agents for the Treatment of Campylobacter Species in the Crop of a Bird |
| 02/24/2011 | US20110044968 Compositions for treatment with metallopeptidases, methods of making and using the same |
| 02/24/2011 | US20110044967 Conjugates Comprising a Biodegradable Polymer and Uses Therefor |
| 02/24/2011 | US20110044966 Use of a substance for manufacturing of a medicament for treatment of common cold |
| 02/24/2011 | US20110044965 L-citrulline for treating endothelial dysfunction and erectile dysfunction |
| 02/24/2011 | US20110044964 Plant-based omega chewable supplement |
| 02/24/2011 | US20110044963 Method of Testing a Patient for Hypertension and Related Method of Treatment and Test Kit |
| 02/24/2011 | US20110044960 Medicament, dental material, and method of screening |
| 02/24/2011 | US20110044956 Nell-1 enhanced bone mineralization |
| 02/24/2011 | US20110044955 Altering memory by affecting staufen |
| 02/24/2011 | US20110044951 Compositions for preparing a coffee beverage comprising hydrolysed chlorogenic acid |
| 02/24/2011 | US20110044947 Methods of treating cardiac disorders |
| 02/24/2011 | US20110044946 Genetec regulation of host defense mechanisms by mucosal exposure to natural interferon alpha species |
| 02/24/2011 | US20110044945 Agents for the treatment of multiple sclerosis and methods of using same |
| 02/24/2011 | US20110044944 Anti-inflammatory compositions for treating brain inflammation |
| 02/24/2011 | US20110044943 Anti-Viral Compounds, Compositions, And Methods Of Use |
| 02/24/2011 | US20110044942 Methods of treatment for solid tumors |
| 02/24/2011 | US20110044941 Immunotherapy for reversing immune suppression |
| 02/24/2011 | US20110044940 Thiazole Carboxamide Derivatives and Their Use to Treat Cancer |
| 02/24/2011 | US20110044939 Regulatory t cells in adipose tissue |
| 02/24/2011 | US20110044938 Tetrahydrobenzothiophene derivatives |
| 02/24/2011 | US20110044937 Staged immune-response modulation in oncolytic therapy |
| 02/24/2011 | US20110044921 Substances and compositions for enhancing dna repair and methods of use |
| 02/24/2011 | US20110044912 Diagnostic And Therapeutic Epitope, And Transgenic Plant |
| 02/24/2011 | US20110044905 Oxytocin analogues |
| 02/24/2011 | US20110044903 Methods for producing microbubbles |